Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al. that evaluated TOF effic...
29 Jan 9min
Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor Reike Alten will be reviewing two papers. The firs...
18 Des 202522min
Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional s...
11 Des 202513min
Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secu...
4 Des 202520min
Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two papers. The first paper, by Hernández-Hernánd...
27 Nov 20259min
Author Interview: Professor Filip Rob, 2025
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Filip Rob, the Department of head of the Dermatovenereology at the Second Faculty of Medicine, Charles University, Uni...
20 Nov 202525min
Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2
Webinar highlights! Join Professor Iain McInnes and Drs Grace Wright and Melinda Gooderham as they discuss advancing patient care through an interdisciplinary approach to IMIDs. This webinar provides ...
16 Nov 202517min
Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interva...
13 Nov 202514min
